Understanding how chondrocytes respond to joint injuries
SIRT1 Signaling in Injurious Chondrocyte Mechaotransduction
This study is looking at how cartilage cells react to joint injuries that can lead to arthritis, and it's trying to find new ways to help prevent or slow down this condition by focusing on a specific molecule called SIRT1.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Purdue University NIH-funded |
| Lab location | 1 site (West Lafayette, United States) |
| Project ID | NIH-11123596 on NIH RePORTER |
What this research studies
This research investigates how chondrocytes, the cells in cartilage, respond to mechanical overloads caused by joint injuries, which can lead to post-traumatic osteoarthritis (PTOA). The study aims to identify the signaling pathways that regulate the response of these cells to injury, particularly focusing on a molecule called SIRT1. By using pharmacological inhibitors and advanced genetic techniques, the researchers hope to uncover new therapeutic targets that could help prevent or delay the progression of PTOA. This work is crucial as cartilage has limited ability to heal itself after injury.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced high-energy trauma to their joints and are at risk of developing post-traumatic osteoarthritis.
Not a fit: Patients with pre-existing osteoarthritis unrelated to joint trauma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve recovery from joint injuries and reduce the risk of developing osteoarthritis.
How similar studies have performed: Other research has shown promise in targeting mechanosensitive pathways in cartilage, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
West Lafayette, United States
- Purdue University — West Lafayette, United States (Active)
Researchers
- Principal investigator: Wagner, Diane — Purdue University
- Study coordinator: Wagner, Diane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.